Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26597. Epub 2017 Apr 25.

Authors

Emilie Bouquet¹, Anne Jourdain², Marie-Christine Machet^{3

4}, Frédérique Beau-Salinas¹, Annie-Pierre Jonville-Béra¹

Affiliations

¹ Department of Clinical Pharmacology and Regional Pharmacovigilance Center, University Hospital, CHRU Tours, Tours, France.
² Department of Pediatric Oncohematology, University Hospital, CHRU Tours, Tours, France.
³ Department of Pathology, University Hospital, CHRU Tours, Tours, France.
⁴ University Francois Rabelais, Tours, France.

PMID: 28439970
DOI: 10.1002/pbc.26597

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Adolescent
Antineoplastic Agents / adverse effects*
Dasatinib / adverse effects*
Humans
Hyperplasia / chemically induced
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Lymphadenopathy / chemically induced*
Male

Substances

Antineoplastic Agents
Dasatinib